Yusimry

Active Ingredient(s): Adalimumab-aqvh
FDA Approved: * December 17, 2021
Pharm Company: * COHERUS BIOSCIENCES INC
Category: Immunosuppressive

Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5] Common side effects include upper respiratory tract infections, pain at the site o... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Yusimry 40 mg/.8ml Subcutaneous Injection, Solution
NDC: 70114-210
Labeler:
Coherus Biosciences Inc
Yusimry 40 mg/.8ml Subcutaneous Injection, Solution
NDC: 70114-220
Labeler:
Coherus Biosciences Inc

Related Brands

Drugs with the same active ingredients